Brief: Dexcom Q3 Adjusted EPS USD 0.61 Vs. IBES Estimate USD 0.57
30/10/2025 20:02
Oct 30 (Reuters) - Dexcom Q3 revenue USD 1,209 million vs. IBES estimate USD 1,178 million. Q3 adjusted operating income USD 272.9 million vs. IBES estimate USD 270.7 million Q3 gross profit USD 731.4 million Q3 adjusted gross profit USD 741.3 million Q3 adjusted net income USD 242.5 million vs. IBES estimate USD 226.5 million Q3 operating income USD 242.5 million
Recent news on DexCom
See all newsU.S. RESEARCH ROUNDUP-Ferrari, Hawkeye 360, Micron Technology
FDA clears first over-the-counter glucose monitor for children
Brief: FDA Clears For Marketing Dexcom's Stelo Glucose Biosensor System For Children
Pharmsource says it was unaware Dexcom sensors it bought were slated for destruction
U.S. RESEARCH ROUNDUP- Apple, Lennar, Toll Brothers